Description
Pharmacological action
Combined laxative.
Sodium citrate is a peptizing agent that displaces bound water found in stool.
Sodium lauryl sulfoacetate dilutes intestinal contents.
Sorbitol enhances the laxative effect by stimulating the flow of water into the intestines.
Increasing the amount of water through peptization and liquefaction helps to soften the stool and facilitates the process of bowel movement.
Laxative effect occurs 5-15 minutes after taking the drug.
Indications
– constipation (including with encopresis)
– preparation for endoscopic (rectoscopy) and X-ray examination of the gastrointestinal tract.
Contraindications
increased individual sensitivity to the components of the drug.
Use during pregnancy and lactation
Adequate and strictly controlled studies involving pregnant women have not been conducted.
the drug is likely to be slightly absorbed into the systemic circulation, when it is used in accordance with the recommendations during pregnancy or during lactation, undesirable effects are not expected for the fetus or infant.
Special instructions
Avoid prolonged use of the drug, if symptoms persist, the patient should consult a doctor.
The patient should be informed that if the medicine has become unusable or has expired, it should not be thrown into wastewater or into the street. It is necessary to put the medicine in a bag and put in a garbage container. These measures will help protect the environment.
Influence on the ability to drive vehicles and control mechanisms
Microlax does not affect the ability to drive vehicles and control mechanisms.
Composition
Solution forrectal administration colorless, opalescent, viscous.
1 ml
sodium citrate 90 mg
sodium lauryl sulfoacetate 70% 12.9 mg,
which corresponds to the sodium content of lauryl sulfoacetate 9 mg
sorbitol solution 70% 893 mg,
which corresponds to the content of sorbitol 625 mg
sorbl 1, auxiliary
glycerol – 125 mg,
purified water – up to 1 ml.
Dosage and administration of
1. Break off the seal on the tip of the tube.
2. Press lightly on the tube so that a drop of the drug lubricates the tip of the enema (to facilitate the administration process).
3. When applying a microclyster of 5 ml in children under 3 years of age, the enema tip should be inserted halfway into the rectum, children over the age of 3 years and adults should be given the enema tip in full length.
4. Squeezing the tube, squeeze out its contents completely.
5. Remove the tip while continuing to squeeze the tube slightly.
Side effects
Adverse reactions that occur during the use of the drug, which were identified during post-registration use, are classified as follows: very often (? 10%), often (? 1%, but
From the digestive system: very rarely – pain in the abdomen (including abdominal discomfort, pain in the upper abdomen), discomfort in the anorectal region, loose stools
Allergic reactions: very rarely – hypersensitivity reactions (eg, urticaria).
Drug interactions
There is a risk of colon necrosis with the simultaneous oral / rectal use of sodium polystyrenesulfonate and sorbitol, which is part of the drug.
Overdose
Currently, cases of overdose are not described.
Storage conditions
The drug should be stored out of the reach of children at a temperature not exceeding 25 ° C.
Term hodnosty
5 years
Medic greasy
topical
